Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

ABSTRACT: Inhibition of SET by siRNA or SET antagonist and CIP2A by siRNA can downregulate c-MYC and c-MYC target genes. Cells were treated with a SET antagonist (1μMOP449) for 12 hours, or siRNA for 48 hours.

ORGANISM(S): Homo sapiens

SUBMITTER: Janghorban M 

PROVIDER: S-ECPF-GEOD-58008 | biostudies-other | 2014 Jun

REPOSITORIES: biostudies-other